Copyright: ©Author(s) 2026.
World J Psychiatry. Apr 19, 2026; 16(4): 112755
Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.112755
Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.112755
Table 1 Baseline data of two groups, mean ± SD
| Indicators | Control group (n = 52) | Research group (n = 54) | χ2 | P value |
| Age (years) | 51.48 ± 7.95 | 51.70 ± 7.96 | 0.142 | 0.887 |
| Sex (male/female) | 28/24 | 33/21 | 0.572 | 0.757 |
| Disease course (months) | 9.19 ± 1.70 | 8.74 ± 2.44 | 1.098 | 0.275 |
| Body mass index (kg/m2) | 23.08 ± 2.37 | 22.28 ± 2.20 | 1.802 | 0.074 |
| Diabetes mellitus (with/without) | 10/42 | 8/46 | 0.366 | 0.545 |
| Hypertension (with/without) | 18/34 | 17/37 | 0.118 | 0.732 |
| Coronary heart disease (with/without) | 6/46 | 10/44 | 1.007 | 0.316 |
- Citation: Shen FF, Lin DX, Li H. Effect of paroxetine on neurological function and psychological state in patients with depression after acute ischemic stroke. World J Psychiatry 2026; 16(4): 112755
- URL: https://www.wjgnet.com/2220-3206/full/v16/i4/112755.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i4.112755